JP2009543802A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009543802A5 JP2009543802A5 JP2009519653A JP2009519653A JP2009543802A5 JP 2009543802 A5 JP2009543802 A5 JP 2009543802A5 JP 2009519653 A JP2009519653 A JP 2009519653A JP 2009519653 A JP2009519653 A JP 2009519653A JP 2009543802 A5 JP2009543802 A5 JP 2009543802A5
- Authority
- JP
- Japan
- Prior art keywords
- nrr
- nhr
- acyl
- independently
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 27
- 125000002252 acyl group Chemical group 0.000 claims 20
- 125000003710 aryl alkyl group Chemical group 0.000 claims 12
- 125000001072 heteroaryl group Chemical group 0.000 claims 10
- 125000001188 haloalkyl group Chemical group 0.000 claims 8
- 125000004404 heteroalkyl group Chemical group 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 125000000304 alkynyl group Chemical group 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 5
- 150000002148 esters Chemical class 0.000 claims 5
- 239000000651 prodrug Substances 0.000 claims 5
- 229940002612 prodrugs Drugs 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 125000005418 aryl aryl group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 claims 3
- 208000005721 HIV Infections Diseases 0.000 claims 3
- 201000001820 human immunodeficiency virus infectious disease Diseases 0.000 claims 3
- 230000002062 proliferating Effects 0.000 claims 3
- 206010027476 Metastasis Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- -1 arylheteroaryl Chemical group 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 200000000023 metastatic cancer Diseases 0.000 claims 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81999706P | 2006-07-11 | 2006-07-11 | |
| US83000606P | 2006-07-11 | 2006-07-11 | |
| PCT/US2007/073285 WO2008008854A2 (en) | 2006-07-11 | 2007-07-11 | Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009543802A JP2009543802A (ja) | 2009-12-10 |
| JP2009543802A5 true JP2009543802A5 (US20070167479A1-20070719-C00034.png) | 2011-09-01 |
Family
ID=38924159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009519653A Pending JP2009543802A (ja) | 2006-07-11 | 2007-07-11 | 医学的疾患の治療のためのジアジン及びトリアジン構造を含むｃｘｃｒ４アンタゴニスト |
Country Status (4)
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007008326A (es) * | 2005-01-07 | 2008-01-16 | Univ Emory | Antagonistas de cxcr4 para el tratamiento de una infeccion por vih. |
| US8338448B2 (en) | 2008-03-28 | 2012-12-25 | Altiris Therapeutics, Inc. | Chemokine receptor modulators |
| WO2011094389A2 (en) * | 2010-01-27 | 2011-08-04 | Emory University | Cxcr4 antagonists for imaging of cancer and inflammatory disorders |
| EP2380597A1 (en) | 2010-04-20 | 2011-10-26 | Technische Universität München | Cyclopeptide derivatives and uses thereof |
| EP2380596A1 (en) | 2010-04-20 | 2011-10-26 | Technische Universität München | Cyclopentapeptide derivatives and uses thereof |
| US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
| JP2014513727A (ja) | 2011-05-16 | 2014-06-05 | ジェンザイム・コーポレーション | Ｃｘｃｒ４拮抗薬の使用 |
| CA2852160A1 (en) | 2011-10-28 | 2013-05-02 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
| WO2013070660A1 (en) | 2011-11-07 | 2013-05-16 | Emory University | Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| KR102055958B1 (ko) | 2011-12-22 | 2019-12-13 | 글리코미메틱스, 인크. | E-셀렉틴 길항제 화합물, 조성물, 및 이용 방법 |
| US9867841B2 (en) | 2012-12-07 | 2018-01-16 | Glycomimetics, Inc. | Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells |
| AU2014396468B2 (en) | 2014-06-06 | 2019-02-21 | Technische Universitat Munchen | Modified cyclopentapeptides and uses thereof |
| JP6689854B2 (ja) | 2014-12-03 | 2020-04-28 | グリコミメティクス， インコーポレイテッド | Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤 |
| US10434195B2 (en) * | 2015-08-03 | 2019-10-08 | Emory University | Methylsulfonamide derivatives and uses related thereto |
| WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
| EP3497131B1 (en) | 2016-08-08 | 2022-03-09 | GlycoMimetics, Inc. | Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4. |
| KR102607640B1 (ko) | 2016-10-07 | 2023-11-28 | 글리코미메틱스, 인크. | 매우 강력한 다량체성 e-셀렉틴 길항물질 |
| WO2018081167A1 (en) | 2016-10-24 | 2018-05-03 | Yumanity Therapeutics | Compounds and uses thereof |
| US11197877B2 (en) | 2017-03-15 | 2021-12-14 | Glycomimetics. Inc. | Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists |
| CN109553604B (zh) * | 2017-09-25 | 2021-08-27 | 盛世泰科生物医药技术(苏州)有限公司 | 4-氨基嘧啶衍生物作cxcr4抑制剂及其应用 |
| CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| EP3717013A1 (en) | 2017-11-30 | 2020-10-07 | GlycoMimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
| AU2018395417B2 (en) | 2017-12-29 | 2023-07-13 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| CA3091454A1 (en) | 2018-03-05 | 2019-09-12 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| JP2022526890A (ja) * | 2019-03-22 | 2022-05-27 | ユマニティ セラピューティクス，インコーポレーテッド | 化合物及びその使用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US776465A (en) * | 1904-04-15 | 1904-11-29 | Charles A Gildemeyer | Spigot. |
| US5993817A (en) | 1995-01-23 | 1999-11-30 | Xenotech | Method to ameliorate osteolysis and metastasis |
| US6358915B1 (en) | 1995-03-07 | 2002-03-19 | George Washington University | Methods for inhibiting metastasis |
| AU6390696A (en) | 1995-06-20 | 1997-01-22 | Trustees Of Boston University | Hypoxia-responsive adhesion molecules, specific antibodies, nd their uses |
| US6344545B1 (en) | 1996-06-14 | 2002-02-05 | Progenics Pharmaceuticals, Inc. | Method for preventing HIV-1 infection of CD4+ cells |
| US5922676A (en) | 1996-09-20 | 1999-07-13 | The Burnham Institute | Methods of inhibiting cancer by using superfibronectin |
| US5874438A (en) | 1996-10-11 | 1999-02-23 | Bayer Aktiengesellschaft | 2,2'-bridged bis-2,4-diaminoquinazolines |
| US6534626B1 (en) | 1997-12-01 | 2003-03-18 | The United States Of America As Represented By The Department Of Health & Human Services | Chemokine variants |
| WO1999047158A2 (en) | 1998-03-13 | 1999-09-23 | The University Of British Columbia | Therapeutic chemokine receptor antagonists |
| WO1999057149A2 (en) | 1998-05-05 | 1999-11-11 | Adherex Technologies, Inc. | Compounds and methods for modulating nonclassical cadherin-mediated functions |
| EP1085890A1 (en) * | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Novel sodium channel drugs and uses |
| US6420354B1 (en) * | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
| EP1050583A4 (en) | 1998-11-24 | 2005-02-02 | Hisamitsu Pharmaceutical Co | INHIBITORS OF HIV INFECTIONS |
| MXPA01009674A (es) | 1999-03-24 | 2003-07-21 | Anormed Inc | Compuestos heterociclicos que se unen a receptores de quimiocina. |
| US6750348B1 (en) * | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| JP2003516324A (ja) | 1999-11-24 | 2003-05-13 | シェーリング コーポレイション | 転移を阻害する方法 |
| EP1171152A4 (en) | 2000-02-03 | 2002-09-25 | Univ Jefferson | CXCR4 vMIP-II PEPTIDE ANTAGONISTS |
| WO2001070727A1 (en) * | 2000-03-23 | 2001-09-27 | Sanofi-Synthelabo | 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives |
| DE60103052T2 (de) | 2000-05-09 | 2005-03-03 | The University Of British Columbia, Vancouver | Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten |
| WO2002002516A2 (en) * | 2000-06-30 | 2002-01-10 | Thomas Jefferson University | Inhibitors of hiv integrase |
| WO2002094261A1 (en) | 2001-05-24 | 2002-11-28 | Kureha Chemical Industry Company, Limited | Cxcr4-antagonistic drugs comprising nitrogen-containing compound |
| JPWO2003029218A1 (ja) | 2001-09-28 | 2005-01-13 | 呉羽化学工業株式会社 | 新規含窒素化合物及びその用途 |
| US7354932B2 (en) | 2001-12-21 | 2008-04-08 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| AU2003261723A1 (en) | 2002-08-27 | 2004-03-19 | Takeda Chemical Industries, Ltd. | Cxcr4 antagonist and use thereof |
| DE10240064A1 (de) | 2002-08-30 | 2004-03-11 | Universitätsklinikum Freiburg | CXCR4-Rezeptor-Antagonisten |
| US20040132642A1 (en) | 2002-11-12 | 2004-07-08 | Government Of The U.S.A., Represented By The Secretary, Dept. Of Health & Human Services | Methods of inhibiting metastasis or growth of a tumor cell |
| US20050002939A1 (en) | 2002-12-23 | 2005-01-06 | Albert Zlotnik | Tumor killing/tumor regression using CXCR4 antagonists |
| EP1608318A4 (en) | 2003-03-27 | 2009-07-29 | Univ Emory | CXCR4 ANTAGONISTS AND METHODS OF USE |
| CA2520259A1 (en) | 2003-04-11 | 2004-10-28 | Anormed Inc. | Cxcr4 chemokine receptor binding compounds |
| IN266744B (US20070167479A1-20070719-C00034.png) | 2003-04-22 | 2015-05-29 | Genzyme Corp | |
| PT1687297E (pt) * | 2003-11-24 | 2014-09-18 | Prometic Biosciences Inc | Dímeros da triazina para o tratamento de doenças autoimunes |
| GB0405193D0 (en) * | 2004-03-08 | 2004-04-21 | Medical Res Council | Compounds |
| AU2006203828B2 (en) | 2005-01-07 | 2009-12-03 | Emory University | CXCR4 antagonists for the treatment of medical disorders |
| MX2007008326A (es) * | 2005-01-07 | 2008-01-16 | Univ Emory | Antagonistas de cxcr4 para el tratamiento de una infeccion por vih. |
| US20080227799A1 (en) | 2006-07-11 | 2008-09-18 | Liotta Dennis C | CXCR4 Antagonists Including Heteroatoms for the Treatment of Medical Disorders |
-
2007
- 2007-07-11 US US11/776,476 patent/US8080659B2/en active Active
- 2007-07-11 WO PCT/US2007/073285 patent/WO2008008854A2/en active Application Filing
- 2007-07-11 EP EP07812814A patent/EP2041067A4/en not_active Withdrawn
- 2007-07-11 JP JP2009519653A patent/JP2009543802A/ja active Pending
